ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0600

A Cohort Study of Retention in Ambulatory Lupus Care Among Medicare Patients with SLE-related Hospitalizations

Maria Schletzbaum1, Carlos Torres2, Amy Kind2, Andrea Gilmore Bykovskyi3, Ann Sheehy2 and Christie Bartels2, 1University of Wisconsin School of Medicine and Public Health, Middleton, WI, 2University of Wisconsin School of Medicine and Public Health, Madison, WI, 3University of Wisconsin - Madison School of Nursing, Madison, WI

Meeting: ACR Convergence 2021

Keywords: Access to care, Disparities, Health Services Research, socioeconomic factors, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Healthcare Disparities in Rheumatology Poster (0594–0622)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: In other conditions that require chronic management, poor retention in ambulatory care is associated with adverse outcomes. We previously identified that living in the most disadvantaged neighborhoods was the greatest predictor of poor care retention among lupus patients in one urban cohort. Given high hospitalization and rehospitalization rates among lupus patients, this study aims to measure rates and predictors of retention in lupus care prior to hospitalization. Results will inform efforts to improve care retention, health disparities, and outcomes for patients with lupus.

Methods: This retrospective cohort study used a 20% random Medicare sample of adult hospitalizations with an SLE diagnosis code from 2013-2014. Inclusion required at least one year of continuous Medicare AB coverage before hospitalization.

Retention in lupus care was measured in the 12 months prior to hospitalization. Visit-based retention in care used an established threshold of at least two ambulatory rheumatologist visits >= 90 days apart. Rates of visit-defined care retention were calculated by sociodemographic and comorbidity groups. Generalized logistic regression, clustered by patient, was performed to identify predictors of care retention.

Results: Among 11,296 SLE-related hospitalizations, the overall observed rate of visit-defined care retention in the year prior to hospitalization was just 36.7%. White, Black, and Hispanic patients had lower rates of retention when compared to Asian/Pacific Islander patients (37.7%, 34.7%, 36.0% vs. 43.4% p=0.02, Table 1). Retention rates for rural-residing patients were significantly lower than suburban (29.5% vs 38.8%, p < 0.001). Hospitalizations associated with the most disadvantaged neighborhood ADI quintile had lower rates of patient retention (32.7% vs 38.5%, p < 0.001). Thirty-day rehospitalization rates were 21.5% among those with baseline retention compared to 23.9% without.

Multivariable analysis showed that women were more often retained (aOR 1.41, 95% CI 1.15-1.73) (Table 2). Rural residents had 26% lower odds of being retained in care when compared to urban residents (0.74, 0.59-0.94). History of Medicaid enrollment, a proxy of low SES, was significantly associated with decreased odds of retention in care (0.73, 0.63-0.85). Similarly, alcohol use (0.54, 0.35-0.84), tobacco use disorders (0.75, 0.64-0.88), and renal failure (0.64, 0.56-0.75) were associated with lower odds of retention in care. Obesity predicted 23% greater odds of retention (1.23, 1.05-1.44). Race/ethnicity and ADI quintile were not significant in the full model. Limitations include potential misclassification of NP/PA visits.

Conclusion: Rural residence and lower SES, indicated by Medicaid eligibility, predicted lower likelihood of retention in ambulatory lupus care prior to hospitalization. Several comorbid conditions, including renal failure, also predicted lower retention. Those retained in care had lower rates of 30-day readmission. Findings highlight the importance of addressing ambulatory access and outreach to retain and re-engage lupus patients in rheumatology care. Results can aid patient-provider communication on the importance of continuity of lupus care.


Disclosures: M. Schletzbaum, None; C. Torres, None; A. Kind, None; A. Gilmore Bykovskyi, None; A. Sheehy, None; C. Bartels, Pfizer, Independent Grants for Learning and Change, 5.

To cite this abstract in AMA style:

Schletzbaum M, Torres C, Kind A, Gilmore Bykovskyi A, Sheehy A, Bartels C. A Cohort Study of Retention in Ambulatory Lupus Care Among Medicare Patients with SLE-related Hospitalizations [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/a-cohort-study-of-retention-in-ambulatory-lupus-care-among-medicare-patients-with-sle-related-hospitalizations/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-cohort-study-of-retention-in-ambulatory-lupus-care-among-medicare-patients-with-sle-related-hospitalizations/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology